Global Offering

 

	SciClone Pharmaceuticals (Holdings) Limited

► COVER ► IMPORTANT ► EXPECTED TIMETABLE ► CONTENTS ► SUMMARY ► DEFINITIONS ► GLOSSARY OF TECHNICAL TERMS ► FORWARD-LOOKING STATEMENTS ► RISK FACTORS ► WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTIONS FROM COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE ► INFORMATION ABOUT THIS PROSPECTUS AND THE GLOBAL OFFERING ► DIRECTORS AND PARTIES INVOLVED IN THE GLOBAL OFFERING ► CORPORATE INFORMATION ► INDUSTRY OVERVIEW ► REGULATORY OVERVIEW ► HISTORY, REORGANIZATION AND CORPORATE STRUCTURE ► BUSINESS ► RELATIONSHIP WITH OUR SINGLE LARGEST SHAREHOLDER ► DIRECTORS AND SENIOR MANAGEMENT ► SHARE CAPITAL ► SUBSTANTIAL SHAREHOLDERS ► FINANCIAL INFORMATION ► FUTURE PLANS AND USE OF PROCEEDS ► CORNERSTONE INVESTORS ► UNDERWRITING ► THE STRUCTURE OF THE GLOBAL OFFERING ► HOW TO APPLY FOR HONG KONG OFFER SHARES ► APPENDIX I - ACCOUNTANT'S REPORT ► APPENDIX II - UNAUDITED PRO FORMA FINANCIAL INFORMATION ► APPENDIX III - PROFIT ESTIMATE ► APPENDIX IV - SUMMARY OF THE CONSTITUTION OF THE COMPANY AND CAYMAN COMPANY LAW ► APPENDIX V - STATUTORY AND GENERAL INFORMATION ► APPENDIX VI - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES IN HONG KONG AND AVAILABLE FOR INSPECTION ► BACK COVER